Quantitative assessment of neuroprotection against NMDA-induced brain injury
dc.contributor.author | McDonald, John W. | en_US |
dc.contributor.author | Roeser, Nancy F. | en_US |
dc.contributor.author | Silverstein, Faye Sarah | en_US |
dc.contributor.author | Johnston, Michael V. | en_US |
dc.date.accessioned | 2006-04-07T20:37:57Z | |
dc.date.available | 2006-04-07T20:37:57Z | |
dc.date.issued | 1989-12 | en_US |
dc.identifier.citation | McDonald, John W., Roeser, Nancy F., Silverstein, Faye S., Johnston, Michael V. (1989/12)."Quantitative assessment of neuroprotection against NMDA-induced brain injury." Experimental Neurology 106(3): 289-296. <http://hdl.handle.net/2027.42/27656> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6WFG-4C52H18-J0/2/bfa38a25d09c28cd0942ae03e65ffe98 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/27656 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2687017&dopt=citation | en_US |
dc.description.abstract | In immature rodent brain, unilateral intrastriatal injections of selected excitatory amino acid (EAA) receptor agonists, such as N-methyl--aspartate (NMDA), produce prominent ipsilateral forebrain lesions. In Postnatal Day (PND) 7 rats that receive a right intrastriatal injection of NMDA (25 nmol) and are sacrificed 5 days later, there is a considerable and consistent reduction in the weight of the injected cerebral hemisphere relative to that of the contralateral side (-28.5 +/- 1.9%, n = 6). In animals treated with specific NMDA receptor antagonists, the severity of NMDA-induced damage is markedly reduced. We have previously reported that the efficacy of potential neuroprotective drugs in limiting NMDA-induced lesions can be assessed quantitatively by comparison of hemisphere weights after a unilateral NMDA injection. In this study, we compared three quantitative methods to evaluate the severity of NMDA-induced brain injury and the degree of neuroprotection provided by NMDA receptor antagonists. We characterized the severity of brain injury resulting from intrastriatal injections of 1-50 nmol NMDA in PND 7 rats sacrificed on PND 12 by (i) comparison of cerebral hemisphere weights; (ii) assay of the activity of the cholinergic neuronal marker, choline acetyltransferase (ChAT) activity; and (iii) measurement of regional brain cross-sectional areas. The severity of the resulting brain injury as assessed by comparison of hemisphere weights increased linearly with the amount of NMDA injected into the striatum up to 25 nmol NMDA. The magnitude of injury was highly correlated with the degree of reduction in ChAT activity (r2 = 0.97). Quantification of neuroprotection against NMDA toxicity by measurement of cerebral hemisphere weight disparities was highly correlated with comparisons of hemisphere and striatal cross-sectional areas (r2 = 0.98). The potency and efficacy of the dissociative anesthetic ketamine was easily distinguished from those of two other NMDA receptor antagonists (MK-801, (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-immine maleate and CPP, 3-((+/-)-2-carboxypiperazine-4-yl)-propyl-1-phosphonic acid) using this model. These data demonstrate that this model can be used to accurately quantitate NMDA-induced brain injury and evaluate neuro-protective properties of glutamate antagonists in vivo. | en_US |
dc.format.extent | 940054 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Quantitative assessment of neuroprotection against NMDA-induced brain injury | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Psychiatry | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Neuroscience and Medical Scientist Training Program, University of Michigan, Ann Arbor, Michigan 48109, USA | en_US |
dc.contributor.affiliationum | Department of Neurology, University of Michigan, Ann Arbor, Michigan 48109, USA | en_US |
dc.contributor.affiliationother | Department of Neurology, the Johns Hopkins University School of Medicine, Baltimore, Maryland 21218, USA | en_US |
dc.contributor.affiliationother | Department of Neurology, the Johns Hopkins University School of Medicine, Baltimore, Maryland 21218, USA | en_US |
dc.identifier.pmid | 2687017 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/27656/1/0000037.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0014-4886(89)90162-3 | en_US |
dc.identifier.source | Experimental Neurology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.